Clinical Trials Browser

Carcinoma, Renal Cell × Radium-223 × Clear all

NCT02406521 2020-03-04

Exploratory Study of Radium-223 and VEGF-Targeted Therapy in Patients With Metastatic Renal Cell Carcinoma and Bone Mets

Phase 1 Completed

Carcinoma, Renal Cell